Peptides which inhibit complement activation
    1.
    发明授权
    Peptides which inhibit complement activation 有权
    抑制补体活化的肽

    公开(公告)号:US06319897B1

    公开(公告)日:2001-11-20

    申请号:US09142680

    申请日:1999-02-01

    IPC分类号: A61K3812

    摘要: Peptides capable of inhibiting complement activation are provided. Methods of inhibiting complement activation and complement-mediated tissue injury using these peptides are also provided. In addition, a method of producing compositions capable of inhibiting complement activation using these peptides is provided, along with the peptide analogs and peptidomimetics produced by the method.

    摘要翻译: 提供能够抑制补体活化的肽。 还提供了使用这些肽抑制补体激活和补体介导的组织损伤的方法。 此外,提供了能够使用这些肽抑制补体活化的组合物的方法,以及通过该方法制备的肽类似物和肽模拟物。

    Factor H binding peptides and uses thereof
    2.
    发明授权
    Factor H binding peptides and uses thereof 有权
    因子H结合肽及其用途

    公开(公告)号:US08962795B2

    公开(公告)日:2015-02-24

    申请号:US13994485

    申请日:2011-12-19

    申请人: John D. Lambris

    发明人: John D. Lambris

    摘要: Factor H-binding peptides that binds to a region of factor H that does not impede the complement-inhibitory activity of factor H are disclosed. When immobilized onto the surface of a biomaterial, these peptides recruit factor H, resulting in a substantial inhibition of biomaterial-induced complement activation in a biological substance exposed to the biomaterial.

    摘要翻译: 公开了与不影响因子H的补体抑制活性的因子H区域结合的因子H结合肽。 当固定在生物材料的表面上时,这些肽招募因子H,导致在暴露于生物材料的生物物质中生物材料诱导的补体活化的实质性抑制。

    Factor H Binding Peptides and Uses Thereof
    3.
    发明申请
    Factor H Binding Peptides and Uses Thereof 有权
    因子H结合肽及其用途

    公开(公告)号:US20130344592A1

    公开(公告)日:2013-12-26

    申请号:US13994485

    申请日:2011-12-19

    申请人: John D. Lambris

    发明人: John D. Lambris

    IPC分类号: C07K7/64

    摘要: Factor H-binding peptides that binds to a region of factor H that does not impede the complement-inhibitory activity of factor H are disclosed. When immobilized onto the surface of a biomaterial, these peptides recruit factor H, resulting in a substantial inhibition of biomaterial-induced complement activation in a biological substance exposed to the biomaterial.

    摘要翻译: 公开了与不影响因子H的补体抑制活性的因子H区域结合的因子H结合肽。 当固定在生物材料的表面上时,这些肽招募因子H,导致在暴露于生物材料的生物物质中生物材料诱导的补体活化的实质性抑制。

    Modified Compstatin With Peptide Backbone And C-Terminal Modifications
    4.
    发明申请
    Modified Compstatin With Peptide Backbone And C-Terminal Modifications 有权
    改进的Compstatin与肽骨架和C端修饰

    公开(公告)号:US20120178694A1

    公开(公告)日:2012-07-12

    申请号:US13318272

    申请日:2010-05-03

    IPC分类号: A61K38/12 C07K7/64

    摘要: Compounds comprising peptides capable of binding C3 protein and inhibiting complement activation are disclosed. These compounds display greatly improved complement activation-inhibitory activity as compared with currently available compounds. The compounds comprise compstatin analogs having a constrained backbone at position 8 (glycine) and, optionally, specific substitutions for threonine at position 13.

    摘要翻译: 公开了包含能够结合C3蛋白并抑制补体活化的肽的化合物。 与目前可获得的化合物相比,这些化合物显示出显着改善的补体活化抑制活性。 该化合物包含在8位(甘氨酸)具有约束主链的化合物抑制物类似物,以及任选地,在13位的苏氨酸的特异性取代。

    Compstatin Analogs with Improved Pharmacokinetic Properties
    6.
    发明申请
    Compstatin Analogs with Improved Pharmacokinetic Properties 有权
    具有改善药代动力学性质的化合物类似物

    公开(公告)号:US20150158915A1

    公开(公告)日:2015-06-11

    申请号:US14343003

    申请日:2012-09-07

    IPC分类号: C07K7/64 A61K45/06 A61K38/12

    摘要: Compounds comprising peptides capable of binding C3 protein and inhibiting complement activation are disclosed. The compounds comprise compstatin analogs in which the N-terminus contains an added or substituted component that improves (1) the peptide's binding affinity to C3 or its fragments, (2) the peptide's solubility in aqueous liquids, (3) the peptide's plasma stability, (4) the peptide's in vivo retention and/or (5) the peptide's bioavailability, as compared with an unmodified compstatin peptide under equivalent conditions. Pharmaceutical compositions and methods of using the compounds are also disclosed.

    摘要翻译: 公开了包含能够结合C3蛋白并抑制补体活化的肽的化合物。 化合物包括其中N末端含有加成或取代的成分的化合物类似物,其改善(1)肽对C3或其片段的结合亲和力,(2)肽在水性液体中的溶解度,(3)肽的血浆稳定性, (4)与等效条件下未修饰的化合物肽相比,肽的体内保留和/或(5)肽的生物利用度。 还公开了使用该化合物的药物组合物和方法。

    Compstatin analogs with improved activity
    8.
    发明授权
    Compstatin analogs with improved activity 有权
    补充剂类似物具有改善的活性

    公开(公告)号:US07989589B2

    公开(公告)日:2011-08-02

    申请号:US10528496

    申请日:2003-09-22

    申请人: John D. Lambris

    发明人: John D. Lambris

    IPC分类号: A61K38/10 A61K38/00 A61K51/00

    CPC分类号: C07K7/08 A61K38/10 C07K14/472

    摘要: Compounds comprising peptides and peptidomimetics capable of binding the C3 protein and inhibiting complement activation are disclosed. These compounds display improved complement activation-inhibitory activity as compared with currently available compounds. Isolated nucleic acid molecules encoding the peptides are also disclosed.

    摘要翻译: 公开了包含能够结合C3蛋白和抑制补体活化的肽和肽模拟物的化合物。 与目前可获得的化合物相比,这些化合物显示出改进的补体活化抑制活性。 还公开了编码肽的分离的核酸分子。